GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

Interestingly, Complan’s competitor and the country’s biggest health drink brand Horlicks (currently owned by GSK Consumer Healthcare) is also on the block since March. It has a market share ...

Horlicks has unveiled its first TV ad campaign in 20 years, in partnership with Sky Media. The month-long campaign, which kicks off from today [19 February 2024], utilises Sky Media’s targeting ...

GlaxoSmithKline (GSK) has accelerated the review of its Horlicks business in India, hoping to sell it for over $4 billion and potentially use the cash for Novartis' buy out deal. Bloomberg ...